ANALISIS EFEKTIVITAS BIAYA PENGGUNAAN AMLODIPIN DIBANDINGKAN KAPTOPRIL PADA PASIEN HIPERTENSI DI RUMAH SAKIT UMUM DAERAH MAJENE PERIODE JANUARI HINGGA JUNI TAHUN 2019
Hypertension is a chronic disease that requires long-term treatment and high cost. The research aimed to determine a more cost-effective treatment between amlodipine and captopril in hypertensive patients at Majene Hospital from January to June 2019. The sampling technique was purposive sampling wi...
| Main Authors: | , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Sekolah Tinggi Ilmu Kesehatan ISFI Banjarmasin
2021-10-01
|
| Series: | JIIS: Jurnal Ilmiah Ibnu Sina |
| Subjects: | |
| Online Access: | https://ojs32.jurnalstikesdarmo.id/index.php/JIIS/article/view/718 |
| _version_ | 1797942824086274048 |
|---|---|
| author | Andi Maulana Kamri Rachmat Kosman Dian Rahayu |
| author_facet | Andi Maulana Kamri Rachmat Kosman Dian Rahayu |
| author_sort | Andi Maulana Kamri |
| collection | DOAJ |
| description |
Hypertension is a chronic disease that requires long-term treatment and high cost. The research aimed to determine a more cost-effective treatment between amlodipine and captopril in hypertensive patients at Majene Hospital from January to June 2019. The sampling technique was purposive sampling with a cross-sectional method. The data collection was obtained from medical records and direct medical costs of hypertensive patients who take amlodipine or captopril. The Mann-Whitney statistical test was performed to determine the significant difference between the treatment groups. The results showed that the Average Cost Effectiveness Rasio (ACER) value of the 5 mg amlodipine and 12.5 mg captopril groups was Rp. 4233.3 and Rp. 4904 with an Incremental Cost Effectiveness rasio (ICER) value of Rp. 1063.5. Meanwhile, the Average Cost Effectiveness Rasio (ACER) value of the 10 mg amlodipine and 25 mg captopril group was Rp. 3764,7 and Rp. 4875.1. In conclusion, amlodipine is more cost effective than captopril.
|
| first_indexed | 2024-04-10T20:14:44Z |
| format | Article |
| id | doaj.art-a5929561c5ae4767a5a447ef70a3e0eb |
| institution | Directory Open Access Journal |
| issn | 2502-647X 2503-1902 |
| language | English |
| last_indexed | 2024-04-10T20:14:44Z |
| publishDate | 2021-10-01 |
| publisher | Sekolah Tinggi Ilmu Kesehatan ISFI Banjarmasin |
| record_format | Article |
| series | JIIS: Jurnal Ilmiah Ibnu Sina |
| spelling | doaj.art-a5929561c5ae4767a5a447ef70a3e0eb2023-01-26T07:48:17ZengSekolah Tinggi Ilmu Kesehatan ISFI BanjarmasinJIIS: Jurnal Ilmiah Ibnu Sina2502-647X2503-19022021-10-0162ANALISIS EFEKTIVITAS BIAYA PENGGUNAAN AMLODIPIN DIBANDINGKAN KAPTOPRIL PADA PASIEN HIPERTENSI DI RUMAH SAKIT UMUM DAERAH MAJENE PERIODE JANUARI HINGGA JUNI TAHUN 2019Andi Maulana Kamri0Rachmat Kosman1Dian Rahayu2Fakultas Farmasi, Universitas Muslim Indonesia, MakassarFakultas Farmasi, Universitas Muslim Indonesia, MakassarFakultas Farmasi, Universitas Muslim Indonesia, Makassar Hypertension is a chronic disease that requires long-term treatment and high cost. The research aimed to determine a more cost-effective treatment between amlodipine and captopril in hypertensive patients at Majene Hospital from January to June 2019. The sampling technique was purposive sampling with a cross-sectional method. The data collection was obtained from medical records and direct medical costs of hypertensive patients who take amlodipine or captopril. The Mann-Whitney statistical test was performed to determine the significant difference between the treatment groups. The results showed that the Average Cost Effectiveness Rasio (ACER) value of the 5 mg amlodipine and 12.5 mg captopril groups was Rp. 4233.3 and Rp. 4904 with an Incremental Cost Effectiveness rasio (ICER) value of Rp. 1063.5. Meanwhile, the Average Cost Effectiveness Rasio (ACER) value of the 10 mg amlodipine and 25 mg captopril group was Rp. 3764,7 and Rp. 4875.1. In conclusion, amlodipine is more cost effective than captopril. https://ojs32.jurnalstikesdarmo.id/index.php/JIIS/article/view/718amlodipinecaptoprilhypertensioncost-effective |
| spellingShingle | Andi Maulana Kamri Rachmat Kosman Dian Rahayu ANALISIS EFEKTIVITAS BIAYA PENGGUNAAN AMLODIPIN DIBANDINGKAN KAPTOPRIL PADA PASIEN HIPERTENSI DI RUMAH SAKIT UMUM DAERAH MAJENE PERIODE JANUARI HINGGA JUNI TAHUN 2019 JIIS: Jurnal Ilmiah Ibnu Sina amlodipine captopril hypertension cost-effective |
| title | ANALISIS EFEKTIVITAS BIAYA PENGGUNAAN AMLODIPIN DIBANDINGKAN KAPTOPRIL PADA PASIEN HIPERTENSI DI RUMAH SAKIT UMUM DAERAH MAJENE PERIODE JANUARI HINGGA JUNI TAHUN 2019 |
| title_full | ANALISIS EFEKTIVITAS BIAYA PENGGUNAAN AMLODIPIN DIBANDINGKAN KAPTOPRIL PADA PASIEN HIPERTENSI DI RUMAH SAKIT UMUM DAERAH MAJENE PERIODE JANUARI HINGGA JUNI TAHUN 2019 |
| title_fullStr | ANALISIS EFEKTIVITAS BIAYA PENGGUNAAN AMLODIPIN DIBANDINGKAN KAPTOPRIL PADA PASIEN HIPERTENSI DI RUMAH SAKIT UMUM DAERAH MAJENE PERIODE JANUARI HINGGA JUNI TAHUN 2019 |
| title_full_unstemmed | ANALISIS EFEKTIVITAS BIAYA PENGGUNAAN AMLODIPIN DIBANDINGKAN KAPTOPRIL PADA PASIEN HIPERTENSI DI RUMAH SAKIT UMUM DAERAH MAJENE PERIODE JANUARI HINGGA JUNI TAHUN 2019 |
| title_short | ANALISIS EFEKTIVITAS BIAYA PENGGUNAAN AMLODIPIN DIBANDINGKAN KAPTOPRIL PADA PASIEN HIPERTENSI DI RUMAH SAKIT UMUM DAERAH MAJENE PERIODE JANUARI HINGGA JUNI TAHUN 2019 |
| title_sort | analisis efektivitas biaya penggunaan amlodipin dibandingkan kaptopril pada pasien hipertensi di rumah sakit umum daerah majene periode januari hingga juni tahun 2019 |
| topic | amlodipine captopril hypertension cost-effective |
| url | https://ojs32.jurnalstikesdarmo.id/index.php/JIIS/article/view/718 |
| work_keys_str_mv | AT andimaulanakamri analisisefektivitasbiayapenggunaanamlodipindibandingkankaptoprilpadapasienhipertensidirumahsakitumumdaerahmajeneperiodejanuarihinggajunitahun2019 AT rachmatkosman analisisefektivitasbiayapenggunaanamlodipindibandingkankaptoprilpadapasienhipertensidirumahsakitumumdaerahmajeneperiodejanuarihinggajunitahun2019 AT dianrahayu analisisefektivitasbiayapenggunaanamlodipindibandingkankaptoprilpadapasienhipertensidirumahsakitumumdaerahmajeneperiodejanuarihinggajunitahun2019 |